Vanguard Group Inc Ocugen, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,521,167 shares of OCGN stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,521,167
Previous 11,999,551
29.35%
Holding current value
$15.4 Million
Previous $19.7 Million
22.25%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OCGN
# of Institutions
108Shares Held
66.5MCall Options Held
516KPut Options Held
272K-
Black Rock Inc. New York, NY17.9MShares$17.7 Million0.0% of portfolio
-
State Street Corp Boston, MA14.8MShares$14.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.9MShares$5.85 Million0.0% of portfolio
-
Rafferty Asset Management, LLC New York, NY1.08MShares$1.07 Million0.01% of portfolio
-
Ci Private Wealth, LLC Miami, FL900KShares$891,1280.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $214M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...